drugset / Trial / NCT06648655

A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder

NCT06648655 ↗

Phase 2 Terminated 110 enrolled Tempero Bio, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

TMP-301 has been shown in preclinical models to reduce consumption of alcohol and other addictive substances. It has been tested in healthy subjects and has been found to be safe and tolerated at doses predicted to be efficacious in alcohol use disorder. This study is being conducted to evaluate the safety, tolerability and efficacy of TMP-301 in patients with alcohol use disorder.

Timeline

Start
2024-11-14
Primary completion
2025-10-13
Completion
2025-11-14

Outcome

Outcome not reported

Stopped: “Study was terminated due to serious adverse event (SAE)”

Drugs

EvaluationDrugModalityDoseRoute
Subject TMP-301 Unknown — —